14.60
-8.86%
Close of 20 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $3.32bn
- Last close × shares
- Volume
- 16.1m
- Shares, 20 Nov 2026
- Price to earnings
- 47.3
About Hims & Hers Health
From its filings with the US Securities and Exchange Commission
Hims & Hers Health is based in San Francisco, California and is incorporated in Delaware. Its shares trade on NYSE under the ticker HIMS. The SEC classifies its business as offices & clinics of doctors of medicine. In the fiscal year to 31 December 2025, it reported revenue of $2.35bn and net income of $128.4m. At that date it held total assets of $2.15bn and shareholders' equity of $540.9m. By region, United States Revenue accounted for 94.3%, followed by Rest of the World Revenue at 5.7%.
Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, “Hims & Hers”, the “Company”, “we”, “us” or “our”) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format. The Hims & Hers platforms (collectively, our “platform”) include access to a highly-qualified and technologically-innovative provider network, an electronic medical record system designed to support providers and customers, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Our digital platform enables access to treatments for a broad range of chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. Hims & Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate, including through personalized treatment plans, with prescriptions fulfilled online through licensed pharmacies. In addition, we also offer access to a range of non-prescription health and wellness products. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness.
Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗
Latest on Hims & Hers Health
Our reporting
- Hims & Hers Health falls 8.86% in Friday's session
- Hims & Hers Health falls 6.04% in Thursday's session
- Hims & Hers Health falls 2.85% in Wednesday's session
- Hims & Hers Health falls 5.44% in Tuesday's session
- Hims & Hers Health falls 5.93% in Monday's session
- Hims & Hers Health falls 5.19% in Thursday's session
Next results
Due on 22 Feb 2027. Analysts expect earnings of 0.02 a share.
Other Health Care listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Hims & Hers Health's ticker?
Hims & Hers Health trades as HIMS on its US listing, under ISIN US4330001060.
What was Hims & Hers Health's last closing price?
14.60 on 20 Nov 2026. The figure is in USD and is never converted.
When does Hims & Hers Health next report results?
Results are expected on 9 Nov 2026, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.